Sempar Petit Berry 10 Tablets [Class 2 OTC Drug]

• Product Description

  Product Information

  Motion sickness medicine
  
  ◆Sempaa Petit Berry prevents and relieves dizziness, nausea, and headache caused by motion sickness. It is also recommended for people who want to enjoy travel and long outings, and for children who want to enjoy school trips.
  ◆It can be taken by children aged 3 years and older as well as adults. It is a small strawberry-flavored chewable tablet that children like.
  ◆It can be taken right away without water, whether in the rush before going out or if you start to feel sick on the way.
  

  About the Sale of Medicines

  
  ●Precautions for Use
  ■■Things You Must Not Do■■ (Not following these may worsen current symptoms or make side effects or accidents more likely)
  1. While taking this medicine, do not use any of the following medicines: other motion sickness medicines, cold medicines, antipyretic analgesics, sedatives, antitussive and expectorants, gastrointestinal analgesic antispasmodics, oral medicines containing antihistamines, etc. (oral medicines for rhinitis, allergy medicines, etc.)
  2. Do not drive a vehicle or operate machinery after taking this medicine (symptoms such as drowsiness, blurred vision, or abnormal glare may appear)
  ■■Things To Consult On■■
  1. The following persons should consult a doctor, pharmacist, or registered salesclerk before taking this medicine.
  (1) Persons receiving treatment from a doctor.
  (2) Persons who are pregnant or who think they may be pregnant.
  (3) Elderly persons.
  (4) Persons who have had allergic symptoms caused by medicines, etc.
  (5) Persons with the following symptom.
  Difficulty urinating
  (6) Persons who have received the following diagnoses.
  Glaucoma, heart disease
  2. If any of the following symptoms appear after taking this medicine, they may be side effects. Stop taking it immediately and consult a doctor, pharmacist, or registered salesclerk, bringing these instructions with you.
  
  Relevant Area – Symptoms
  Skin – Rash/redness, itching
  Psychiatric/nervous system – Headache
  Urinary system – Difficulty urinating
  Other – Facial flushing, abnormal glare
  
  The following serious symptoms may occur rarely.
  In that case, see a doctor immediately.
  
  Symptom Name – Symptoms
  Aplastic anemia – Bruises, nosebleeds, bleeding from the gums, fever, skin or mucous membranes appearing pale,
  fatigue, palpitations, shortness of breath, feeling unwell and lightheaded, blood in the urine, etc. appear.
  
  Agranulocytosis – Sudden high fever, chills, sore throat, etc. appear.
  
  3. The following symptoms may appear after taking this medicine. If they persist or worsen, stop taking it and consult a doctor, pharmacist, or registered salesclerk, bringing these instructions with you. Dry mouth, constipation, drowsiness, blurred vision
  
  
  ●Indications
  Prevention and relief of dizziness, nausea, and headache caused by motion sickness
  
  
  ●Dosage and Administration
  Take the following dose by chewing it or letting it dissolve in the mouth.
  To prevent motion sickness, take it 30 minutes before boarding a vehicle or vessel.
  If an additional dose is needed, take a single dose with an interval of at least 4 hours.
  Age – Single dose – Times taken
  11 years and older – 2 tablets – Up to 2 times a day
  3 years to 10 years – 1 tablet – Up to 2 times a day
  Under 3 years – Do not take.
  
  [Precautions]
  (1) Strictly follow the dosage and administration.
  (2) When giving this medicine to a child, do so under the guidance and supervision of a parent or guardian.
  (3) When giving this medicine to a young child aged 3 years or older, take good care that the tablet does not get stuck in the throat.
  (4) How to take out the tablets
  Press the raised part of the PTP sheet containing the tablet firmly with your fingertip to break the aluminum foil on the back, take the tablet out, and take it. (If the sheet is swallowed by mistake, it may lead to unexpected accidents such as piercing the mucous membrane of the esophagus)
  
  
  ●Ingredients and Amounts
  2 tablets contain
  Ingredient – Amount – Action
  Chlorpheniramine maleate – 2.66 mg
  – Blocks the transmission of stimuli to the vomiting center and suppresses dizziness, nausea, and headache.
  
  Scopolamine hydrobromide hydrate – 0.16 mg
  – Calms the excited state of the autonomic nerves and suppresses dizziness and nausea.
  
  Additives: reduced maltose starch syrup, corn starch, hydroxypropylcellulose, light anhydrous silicic acid, aspartame (L-phenylalanine compound), magnesium stearate, flavoring, vanillin, ethyl vanillin
  
  
  ●Precautions for Storage and Handling
  (1) Store in a cool place with low humidity, away from direct sunlight.
  (2) Store out of the reach of children.
  (3) Do not transfer to another container.
  (This may cause misuse or change the quality)
  (4) Do not take the product after the expiration date.
  
  [Other information in the package insert] To avoid motion sickness, please also note the following points: Try to get enough sleep the night before.
  Choose a seat at the front or by the window, where it is easier to feel comfortable.
  Avoid drinking or eating too much.
  Stay in a good mood by chatting or looking at the scenery.
  
  
  ●Contact Information
  For inquiries about this product, please contact the store where you purchased it or the following.
  Taisho Pharmaceutical Co., Ltd. Customer 119 Office
  東京都豊島区高田3丁目24番1号 Phone 03-3985-1800
  Hours: 8:30 to 21:00 (excluding Saturdays, Sundays, and public holidays)

Translation Notice

• This product is manufactured and labeled for sale and use in Japan in accordance with Japanese laws and regulations.
• This English product information is a translation of the original Japanese product information and is provided for reference only. It does not guarantee that the product or this information conforms to the laws and regulations of any country other than Japan.
• The translation may contain errors or omissions and may be revised without notice. If there is any discrepancy between this translation and the original Japanese text, the original Japanese text takes precedence. The original is available on the Japanese version of this page.